Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
amgen
boston blog main
boston top stories
clinical trials
inclisiran
life sciences
national blog main
national top stories
new york
new york blog main
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
alirocumab
biotech
cholesterol
deals
evolocumab
fda
novartis
pcsk9
praluent
repatha
rna interference
sanofi
the medicines co.
the medicines company
What
cholesterol
drug
fda
2
×
medco
2
×
medicines
acquire
agreed
billion
bringing
brings
cash
clears
closer
company
compound
deal
filing
inched
lowering
market
morning
new
novartis
phase
poised
positive
preps
ready
result
tests
touting
twice
wave
yearly
Language
unset
Current search:
medco
×
fda
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
